BNP Paribas Knock-Out 4AB/ DE000PF3WV22 /
03/05/2024 21:43:47 | Chg.+0.30 | Bid22:00:43 | Ask22:00:43 | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
5.67EUR | +5.59% | - Bid Size: - |
- Ask Size: - |
ABBVIE INC. D... | 103.2029 - | 31/12/2078 | Call |
GlobeNewswire
02/05
Aprea Therapeutics Announces Appointment of Nadeem Q. Mirza, M.D., M.P.H. as Chief Medical Officer a...
GlobeNewswire
01/05
CytomX Therapeutics to Report First Quarter 2024 Results and Provide an Initial CX-904 Phase 1a Clin...
GlobeNewswire
30/04
CEREVEL SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of Cerevel Therapeutics Holdings,...
GlobeNewswire
30/04
U.S. Commercialization Agreement with Quallent to Drive Patient Savings with First High-Concentratio...
GlobeNewswire
25/04
Morphic Announces Corporate Highlights and Financial Results for the First Quarter 2024
GlobeNewswire
25/04
Nucleome Therapeutics appoints Dr John Davis as Non-Executive Director of the Board and establishes ...
GlobeNewswire
24/04
Coherus Announces Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeti...
GlobeNewswire
23/04
Leaders from Fortune 100 Best Companies to Work For To Share Insights at For All Summit May 7-9
GlobeNewswire
22/04
TAKE ACTION: The M&A Class Action Firm Launches Legal Inquiry for the Merger - ALPN, LABP, SWAV, FUS...
GlobeNewswire
19/04
NurExone Presenting on Revolutionary Spinal Cord Injury Therapy at European Conference on Exosomes a...
GlobeNewswire
19/04
Alvotech signs U.S. agreement to expand access for newly approved high-concentration interchangeable...
GlobeNewswire
18/04
Cerevel Therapeutics Announces Positive Topline Results for Tavapadon in Phase 3 Adjunctive Trial fo...
GlobeNewswire
16/04
Alvotech and Teva Announce U.S. FDA Approval of SELARSDI™ (ustekinumab-aekn), biosimilar to Stelara®...
GlobeNewswire
16/04
OSE Immunotherapeutics’ Global License to Develop a Novel Monoclonal Antibody for the Treatment of C...
GlobeNewswire
16/04
Nxera Pharma Notes Successful Development Progress of Partnered Schizophrenia Candidate NBI-1117568
GlobeNewswire
15/04
Ocular Therapeutix™ Executive Chairman Pravin U. Dugel, MD Becomes President and CEO Antony Mattessi...
Newsfile Corp
12/04
Allergan Aesthetics and University Lab Partners Announce the Golden Ticket Pitch Competition to Acce...